Skip to content
Research Formulation Education

Where cannabinoid
research becomes
real products.

GCRC connects cannabinoid research, formulation, education and brand development to move plant medicine ideas into practical projects.

6
Consumer brands
5
Pharmaceutical trademarks
2
Research initiatives
Scientist studying a plant extract sample in the Global Cannabinoid Research Center laboratory
A GCRC brand Open to partners

Researcher®

The endocannabinoid system is a signaling network found throughout the body that helps regulate many everyday functions. Researcher® is built around educating people on that system and on the variety of cannabinoids the hemp plant offers, not just one or two.

  • ECS balance
  • Acidic cannabinoids
  • Minor cannabinoid variety

ECS Balance

Daily soft gel and tincture concepts designed around consistent use and cannabinoid variety.

The Foundation

Concepts centered on the acidic cannabinoids CBGa, CBDa and CBCa.

Minor Cannabinoid Complex

A broader spectrum of lesser known cannabinoids working together in one formula.

Partnerships

Partner with GCRC.

GCRC works with manufacturers, distributors, retailers, research sponsors and qualified pharmaceutical collaborators to bring research and brands forward.

Formulation and reformulation

From a product idea to a formula a manufacturer can run.

GCRC develops new cannabinoid formulations and improves existing ones for brands across the cannabis and plant medicine industry, from tinctures and soft gels to topicals and drinks.

  • New product formulation and prototype development
  • Reformulation for taste, texture, consistency or compatibility
  • Cannabinoid and ingredient selection, including minor and acidic cannabinoids
  • Terpenes, flavor and delivery strategy
  • Phyto food science and formulation
  • Preparation for manufacturing handoff
Cannabinoid formulation work in a research laboratory
Entire brand reformulationor a single product, scoped to your goals
  1. Project inquiry

    Tell us the product, the format and the goal.

  2. Scope discussion

    We agree the work, timeline and responsibilities.

  3. Development

    Ingredient selection, formulation and testing plan.

  4. Prototype review

    You evaluate the prototype and we refine it.

  5. Manufacturing handoff

    A formula ready for your production partner.

Research and education

Our food should be our path to health.

GCRC research looks at how plants, nutrition and lifestyle support the body, and turns what it learns into education that people and professionals can use.

In development

Consumers

ECS basics, cannabinoid literacy and understanding what is in a product.

In development

Industry

Brand, retail, formulation and manufacturing communication.

In development

Brands and products

Documented standards and review criteria for cannabinoid products.

In development

Healthcare professionals

ECS literacy to support informed professional conversations.

Intellectual property

Prototypes created for preclinical research.

GCRC holds five pharmaceutical trademarks. Each represents a research direction and prototype concept available for qualified pharmaceutical partnerships, sponsored development and formulation work.

01

Prevent®

Prototype research
  • Oncology
  • Infectious disease
02

Genevex®

Prototype research
  • Pain management
  • Spray delivery format
  • Oncology
03

Indole-A™

Indole alkaloid solutions
  • Oncology
  • Infectious disease
  • Broader development
04

NANO®

Prototype research
  • Skin applications
  • Hair growth
  • Oncology
  • Infectious disease
05

NANO CFP®

Preservative concept
  • Carcinogen free preservative concept
  • Pharmaceutical formulation
Mike Robinson, founder of the Global Cannabinoid Research Center
Mike RobinsonFounder
The founder

Built on years of hands on work with patients.

Mike Robinson founded GCRC in 2018 after serving as Director of Consumer Affairs at the American Academy of Cannabinoid Medicine. He brings deep knowledge of cannabinoid formulation and practical experience supporting tens of thousands of patients as a cannabis compassion provider.

Community over competition, worldwide.

Founded GCRC

2018, Santa Barbara, California

Previously

Director of Consumer Affairs, American Academy of Cannabinoid Medicine

Portfolio

Multiple brands, provisional patents and registered trademarks

Focus

Plant health and plant based medicine for nutraceutical and pharmaceutical use

Questions

About GCRC, answered.

Anything else, ask us directly.

What is the Global Cannabinoid Research Center?

The Global Cannabinoid Research Center (GCRC) is a cannabinoid research, formulation, education and brand development organization founded in 2018 in Santa Barbara, California by Mike Robinson. It develops consumer brands such as Researcher®, provides formulation services to the cannabis industry, runs research initiatives and holds pharmaceutical trademarks for prototype concepts.

What does GCRC offer cannabis brands?

GCRC offers new product formulation and reformulation of existing products, including cannabinoid and ingredient selection, minor and acidic cannabinoid work, terpene and flavor development, delivery strategy, prototype development and preparation for manufacturing.

How can my company partner with GCRC?

GCRC works with manufacturers, distributors, retailers, research sponsors and qualified pharmaceutical collaborators. Each partnership pathway, and the brands open to partners, is explained on the Partnerships page.

Are the GCRC pharmaceutical trademarks approved medicines?

No. Prevent®, Genevex®, Indole-A™, NANO® and NANO CFP® represent research directions and prototype concepts created for preclinical research. They are not approved or marketed treatments.

How is GCRC connected to Nanobles and Plant Chat?

GCRC is the research and development partner of Nanobles Corporation. Together they run the Get Balanced® Research Initiative, which conducts structured survey studies through Plant Chat®, a research, education and survey platform.

What is the endocannabinoid system?

The endocannabinoid system (ECS) is a signaling network in the body made up of cannabinoid receptors, the body's own cannabinoids and the enzymes that make and break them down. Research suggests it helps regulate functions such as appetite, mood, memory, pain perception and immune activity.

Work with GCRC

Bring your project to the research table.

Partners, clients and research collaborators, tell us what you are building.

Scroll to Top